These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 18220932)
21. Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease. D'Onofrio G; Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Paroni G; Cascavilla L; Seripa D; Pilotto A Expert Opin Drug Discov; 2012 Jan; 7(1):19-37. PubMed ID: 22468891 [TBL] [Abstract][Full Text] [Related]
22. [Development of Alzheimer's disease treatment based on the molecular mechanism of γ-secretase activity]. Tomita T Rinsho Shinkeigaku; 2012; 52(11):1165-7. PubMed ID: 23196551 [TBL] [Abstract][Full Text] [Related]
23. Novel γ-secretase modulators for the treatment of Alzheimer's disease: a review focusing on patents from 2010 to 2012. Pettersson M; Stepan AF; Kauffman GW; Johnson DS Expert Opin Ther Pat; 2013 Oct; 23(10):1349-66. PubMed ID: 23875696 [TBL] [Abstract][Full Text] [Related]
24. Advances in gamma-secretase modulation. Pissarnitski D Curr Opin Drug Discov Devel; 2007 Jul; 10(4):392-402. PubMed ID: 17659480 [TBL] [Abstract][Full Text] [Related]
25. Independent generation of Abeta42 and Abeta38 peptide species by gamma-secretase. Czirr E; Cottrell BA; Leuchtenberger S; Kukar T; Ladd TB; Esselmann H; Paul S; Schubenel R; Torpey JW; Pietrzik CU; Golde TE; Wiltfang J; Baumann K; Koo EH; Weggen S J Biol Chem; 2008 Jun; 283(25):17049-54. PubMed ID: 18426795 [TBL] [Abstract][Full Text] [Related]